Effect of intravenous administration of ketamine on the minimum alveolar concentration of isoflurane in anesthetized dogs

American Journal of Veterinary Research - Tập 67 Số 1 - Trang 21-25 - 2006
Alberto Solano1, Bruno H. Pypendop2, Pedro Boscan3, Jan E. Ilkiw2
1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA
2Surgical and Radiological Sciences
3UNIVERSITY OF CALIFORNIA AT DAVIS

Tóm tắt

Abstract Objective—To determine the effect of 6 plasma ketamine concentrations on the minimum alveolar concentration (MAC) of isoflurane in dogs. Animals—6 dogs. Procedure—In experiment 1, the MAC of isoflurane was measured in each dog and the pharmacokinetics of ketamine were determined in isoflurane-anesthetized dogs after IV administration of a bolus (3 mg/kg) of ketamine. In experiment 2, the same dogs were anesthetized with isoflurane in oxygen. A target-controlled IV infusion device was used to administer ketamine and to achieve plasma ketamine concentrations of 0.5, 1, 2, 5, 8, and 11 μg/mL by use of parameters obtained from experiment 1. The MAC of isoflurane was determined at each plasma ketamine concentration, and blood samples were collected for ketamine and norketamine concentration determination. Results—Actual mean ± SD plasma ketamine concentrations were 1.07 ± 0.42 μg/mL, 1.62 ± 0.98 μg/mL, 3.32 ± 0.59 μg/mL, 4.92 ± 2.64 μg/mL, 13.03 ± 10.49 μg/mL, and 22.80 ± 25.56 μg/mL for target plasma concentrations of 0.5, 1, 2, 5, 8, and 11 μg/mL, respectively. At these plasma concentrations, isoflurane MAC was reduced by 10.89% to 39.48%, 26.77% to 43.74%, 25.24% to 84.89%, 44.34% to 78.16%, 69.62% to 92.31%, and 71.97% to 95.42%, respectively. The reduction in isoflurane MAC was significant, and the response had a linear and quadratic component. Salivation, regurgitation, mydriasis, increased body temperature, and spontaneous movements were some of the adverse effects associated with the high plasma ketamine concentrations. Conclusions and Clinical Relevance—Ketamine appears to have a potential role for balanced anesthesia in dogs. (Am J Vet Res 2006;67:21–25)

Từ khóa


Tài liệu tham khảo

Fukuda, 2004, Intravenous opioid anesthetics, 410

Ilkiw, 1997, Effect of alfentanil on the minimum alveolar concentration of isoflurane in cats, 58, 1274

Ilkiw, 1994, The cardiovascular sparing effect of fentanyl and atropine, administered to enflurane anesthetized dogs, 58, 248

Steffey, 1994, Morphine-isoflurane interaction in dogs, swine and rhesus monkeys, 17, 202, 10.1111/j.1365-2885.1994.tb00234.x

Valverde, 2004, Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs, 31, 264, 10.1111/j.1467-2995.2004.00165.x

Pypendop, 2005, The effects of intravenous lidocaine administration on the minimum alveolar concentration of isoflurane in cats, 100, 97, 10.1213/01.ANE.0000139350.88158.38

Tranquilli, 1984, Halothane-sparing effect of xylazine in dogs and subsequent reversal with tolazoline, 7, 23, 10.1111/j.1365-2885.1984.tb00874.x

Anis, 1983, The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate, 79, 565, 10.1111/j.1476-5381.1983.tb11031.x

Itzhak, 1989, Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effects of N-methyl-D-aspartate agonists and antagonists, 104, 314, 10.1016/0304-3940(89)90595-8

Lanning, 1975, Ketamine anesthesia, 26, 137, 10.1146/annurev.me.26.020175.001033

Davidson, 1998, Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors, 785, 136, 10.1016/S0006-8993(97)01396-6

Leung, 2001, Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain, 91, 177, 10.1016/S0304-3959(00)00433-4

Vranken, 2004, Treatment of neuropathic cancer pain with continuous intrathecal administration of S +-ketamine, 48, 249, 10.1111/j.0001-5172.2004.00284.x

Wagner, 2002, Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs, 221, 72, 10.2460/javma.2002.221.72

Castroman, 2002, Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder, 96, 1401, 10.1097/00000542-200206000-00020

Berrino, 2003, Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test, 7, 131, 10.1016/S1090-3801(02)00086-1

White, 1975, Interaction of ketamine and halothane in rats, 42, 179, 10.1097/00000542-197502000-00011

Daniell, 1990, The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics, 36, 111, 10.1016/0091-3057(90)90134-4

Muir, 1992, Effects of ketamine infusion on halothane minimal alveolar concentration in horses, 53, 1802

Schwieger, 1991, The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane, 19, 145, 10.1007/BF01073866

Steffey, 1977, Isoflurane potency in the dog and cat, 38, 1833

Valverde, 2003, Validation of several types of noxious stimuli for use in determining the minimum alveolar concentration for inhalation anesthetics in dogs and rabbits, 64, 957, 10.2460/ajvr.2003.64.957

Quasha, 1980, Determination and applications of MAC, 53, 315, 10.1097/00000542-198010000-00008

Eger, 1999, Hypothesis: volatile anesthetics produce immobility by acting on two sites approximately five carbon atoms apart, 88, 1395, 10.1213/00000539-199906000-00036

Steffey, 1974, Hyperthermia and halothane MAC in the dog, 41, 392, 10.1097/00000542-197410000-00017

Kaka, 1980, Pharmacokinetics of ketamine and two metabolites in the dog, 8, 193, 10.1007/BF01065193

Thomson, 1988, Effects of ketamine on liver blood flow and hepatic oxygen consumption. Studies in the anaesthetised greyhound, 32, 10, 10.1111/j.1399-6576.1988.tb02677.x

Sonner, 2003, Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration, 97, 718

Antognini, 1993, Exaggerated anesthetic requirements in the preferentially anesthetized brain, 79, 1244, 10.1097/00000542-199312000-00015

Kingery, 2002, Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception, 96, 367, 10.1097/00000542-200202000-00023

Savola, 1991, Isoflurane and an alpha 2-adrenoceptor agonist suppress nociceptive neurotransmission in neonatal rat spinal cord, 75, 489, 10.1097/00000542-199109000-00017

Stabernack, 2003, Spinal N-methyl-D-aspartate receptors may contribute to the immobilizing action of isoflurane, 96, 102, 10.1213/00000539-200301000-00022

Sumikura, 2003, MAC reduction after intrathecal coadministration of GABA(A) agonist and glutamate antagonist in rats, 17, 92, 10.1007/s005400300023